Corporate & Financial Strategy
  Investor Relations
  Financial Communications

EJ Palmer Consulting

NeRRE Therapeutics

NeRRe Therapeutics is a UK based clinical-stage company developing a unique portfolio of neurokinin (NK) receptor antagonists for the treatment of common debilitating conditions caused by neuronal hypersensitivity.

EJPC has worked with NeRRE Therapeutics on media relations and conference presentations.